Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
Crossref DOI link: https://doi.org/10.1038/nmeth.4553
Published Online: 2018-03-30
Published Print: 2018-04-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lescarbeau, Reynald M
Murray, Bradley
Barnes, Thomas M
Bermingham, Nessan
Text and Data Mining valid from 2018-03-30
Version of Record valid from 2018-03-30
Article History
First Online: 30 March 2018
Competing interests
: The authors are employees of and stockholders in Intellia Therapeutics, Inc.